Pharmacokinetics Services Market-our new study reveals trends, R&D progress, and predicted revenues
Where the Pharmacokinetics Services market is heading? If you are involved in this industry you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 150+ page report provides 70+ tables, 30+ charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our study lets you assess forecasted sales at overall world market and regional level. See financial performance of companies, trends, opportunities, and revenue growth. Much opportunity remains in this growing Pharmacokinetics Services market. See how to exploit the opportunities.
Forecasts to 2030 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares, key player positioning, and an exhaustive product portfolio comparison of key vendors
– You find original analyses, with business outlooks and developments which would be useful to tap potential business areas for key players
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges, SWOT analysis), product profiles and commercial developments.
Report Scope
Global Pharmacokinetics Services market 2020-2030 is segmented on the basis of Drug Type, and geography.
• Revenue and growth forecasts from 2020 to 2030 for the Global Pharmacokinetics Services Market by Drug Type:
– Small Molecules
– Large Molecules
• Revenue and growth forecasts from 2020 to 2030 for the Global Pharmacokinetics Services Market by Region:
– North America: US, Canada
– Europe: Germany, UK, Italy, France, Spain, Rest of Europe
– Asia-Pacific: China, India, Japan, Australia, Rest of Asia-Pacific
– Latin America: Brazil, Mexico, and Rest of Latin America
– Middle East & Africa: GCC, South Africa, Rest of LAMEA
• Our study discusses the selected leading companies that are the major players in the Pharmacokinetics Services industry:
– Evotec AG
– Certara, L.P.
– Pacific BioLabs
– GVK Biosciences Private Limited
– Shanghai Medicilon Inc.
– Pharmaceutical Product Development, LLC
– Charles River Laboratories International, Inc.
– PAREXEL International Corporation
– Eurofins Scientific, Inc.
– Frontage Labs
How the Pharmacokinetics Services Market report helps you
In summary, our 150+ page report provides you with the following knowledge:
– Revenue forecasts to 2030 for each of the above mentioned segments each forecasted at a global and regional level– growth of all segments on regional level helps to understand most lucrative segment.
– Revenue forecasts to 2030 for 5 regional and 10 key national markets – the report highlights market growth prospects for key countries such as the U.S., Canada, Germany, UK, France, Italy, Spain, China, Japan, and India. The report also highlights growth potential in Central & South America as well as Middle East & Africa.
– Prospects for established firms and those seeking to enter the market– including company profiles for over 10 of the major companies involved in the Pharmacokinetics Services market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Pharmacokinetics Services market and leading companies. You will find data, trends and predictions.
The Pharmacokinetics Services Market 2020-2030 report will be of value to anyone who wants to better understand the market and its various segments. It will be useful for businesses who wish to better comprehend the part of the market they are already involved in, or those wishing to enter or expand into a different regional or technical part of the Pharmacokinetics Services industry.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Pharmacokinetics Services Market Report 2020-2030: Forecasts by Drug Type (Small Molecules, Large Molecules) and by Region (North America, Europe, Asia Pacific, Latin America & MEA), Including Forecasts by Major Developed Countries and Developing Countries, Plus Profiles of Leading Companies. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Market Definition
1.2. Why Should You Read This Report?
1.3. How This Report Delivers?
1.4. Key Questions Answered by This Analytical Report:
1.5. Who is this Report for?
1.6. Research Methodology
1.7. Frequently Asked Questions (FAQ)
1.8. About Visiongain
2. Introduction To The Pharmacokinetics Services Market
2.1. What are pharmacokinetics services products?
2.2. Global Pharmacokinetics Services Market Segmentation
2.3. Assumptions For The Study
3. Qualitative Analysis of the Global Pharmacokinetics Services Market
3.1. SWOT Analysis of The Global Pharmacokinetics Services Market
3.2. PESTLE Analysis
3.3. Market Trends
3.4. Drivers
3.4.1. Increase in attrition rate of drugs undergoing clinical trials
3.4.2. The increasing need for drug discovery and drug development
3.4.3. Rising awareness regarding the potential benefits of pharmacokinetics
3.5. Restraints
3.5.1. High cost of pharmacokinetic services
3.6. Opportunity
3.6.1. Technological advancements
4. Global Pharmacokinetics Services Market, by Drug Type, 2020-2030
4.1. Global Pharmacokinetics Services Market Forecast, 2020-2030
4.2. Small Molecules
4.2.1. Pharmacokinetics Services Market for Small Molecules by Region: Market Forecasts 2020-2030
4.3. Large Molecules
4.3.1. Pharmacokinetics Services Market for Large Molecules by Region: Market Forecasts 2020-2030
5. Leading National Markets Forecast 2020-2030
5.1. Geographical Breakdown of Global Pharmacokinetics Services Market, 2019
6. North America Pharmacokinetics Services Market, 2020-2030
6.1. U.S. Pharmacokinetics Services Market Forecast, 2020-2030
6.2. U.S Pharmacokinetics Services Market, Trends and Developments
6.3. Canada Pharmacokinetics Services Market Forecast, 2020-2030
6.4. Canada Pharmacokinetics Services Market, Trends and Developments
7. Europe Pharmacokinetics Services Market, 2020-2030
7.1. Germany Pharmacokinetics Services Market Forecast, 2020-2030
7.2. Germany Pharmacokinetics Services Market, Trends and Developments
7.3. France Pharmacokinetics Services Market Forecast, 2020-2030
7.4. France Pharmacokinetics Services Market, Trends and Developments
7.5. UK Pharmacokinetics Services Market Forecast, 2020-2030
7.6. UK Pharmacokinetics Services Market, Trends and Developments
7.7. Italy Pharmacokinetics Services Market Forecast, 2020-2030
7.8. Italy Pharmacokinetics Services Market, Trends and Developments
7.9. Spain Pharmacokinetics Services Market Forecast, 2020-2030
7.10. Spain Pharmacokinetics Services Market, Trends and Developments
7.11. Rest of Europe Pharmacokinetics Services Market Forecast, 2020-2030
7.12. Rest of Europe Pharmacokinetics Services Market, Trends and Developments
8. Asia Pacific Pharmacokinetics Services Market, 2020-2030
8.1. Japan Pharmacokinetics Services Market Forecast, 2020-2030
8.2. Japan Pharmacokinetics Services Market, Trends and Developments
8.3. China Pharmacokinetics Services Market Forecast, 2020-2030
8.4. China Pharmacokinetics Services Market, Trends and Developments
8.5. India Pharmacokinetics Services Market Forecast, 2020-2030
8.6. India Pharmacokinetics Services Market, Trends and Developments
8.7. Australia Pharmacokinetics Services Market Forecast, 2020-2030
8.8. Australia Pharmacokinetics Services Market, Trends and Developments
8.9. Rest of APAC Pharmacokinetics Services Market Forecast, 2020-2030
8.10. Rest of APAC Pharmacokinetics Services Market, Trends and Developments
9. Latin America Pharmacokinetics Services Market, 2020-2030
9.1. Brazil Pharmacokinetics Services Market Forecast, 2020-2030
9.2. Brazil Pharmacokinetics Services Market, Trends and Developments
9.3. Mexico Pharmacokinetics Services Market Forecast, 2020-2030
9.4. Mexico Pharmacokinetics Services Market, Trends and Developments
9.5. Rest of Latin America Pharmacokinetics Services Market Forecast, 2020-2030
9.6. Rest of Latin America Pharmacokinetics Services Market, Trends and Developments
10. MEA Pharmacokinetics Services Market, 2020-2030
10.1. GCC Countries Pharmacokinetics Services Market Forecast, 2020-2030
10.2. GCC Countries Pharmacokinetics Services Market, Trends and Developments
10.3. South Africa Pharmacokinetics Services Market Forecast, 2020-2030
10.4. South Africa Pharmacokinetics Services Market, Trends and Developments
10.5. Rest of MEA Pharmacokinetics Services Market Forecast, 2020-2030
10.6. Rest of MEA Pharmacokinetics Services Market, Trends and Developments
11. Leading Pharmacokinetics Services Companies
11.1. Evotec AG
11.1.1. Company Overview
11.1.2. Product Portfolio
11.1.3. Sales Analysis
11.2. Certara, L.P.
11.2.1. Company Overview
11.2.2. Product Portfolio
11.2.3. Sales Analysis
11.3. Pacific BioLabs
11.3.1. Company Overview
11.3.2. Product Portfolio
11.3.3. Sales Analysis
11.4. GVK Biosciences Private Limited
11.4.1. Company Overview
11.4.2. Product Portfolio
11.4.3. Sales Analysis
11.5. Shanghai Medicilon Inc.
11.5.1. Company Overview
11.5.2. Product Portfolio
11.5.3. Sales Analysis
11.6. Pharmaceutical Product Development, LLC
11.6.1. Company Overview
11.6.2. Product Portfolio
11.6.3. Sales Analysis
11.7. Charles River Laboratories International, Inc.
11.7.1. Company Overview
11.7.2. Product Portfolio
11.7.3. Sales Analysis
11.8. PAREXEL International Corporation
11.8.1. Company Overview
11.8.2. Product Portfolio
11.8.3. Sales Analysis
11.9. Eurofins Scientific, Inc.
11.9.1. Company Overview
11.9.2. Product Portfolio
11.9.3. Sales Analysis
11.10. Frontage Labs
11.10.1. Company Overview
11.10.2. Product Portfolio
11.10.3. Sales Analysis
12. Conclusion & Recommendations
13. Glossary
13.1. Associated Visiongain Reports
13.2. Visiongain Report Sales Order Form
13.3. About Visiongain
13.4. Visiongain report evaluation form
List of Tables
Table 4.1. Global Pharmacokinetics Services Market, by Drug Type, Forecast ($Mn, AGR%), 2020-2030
Table 4.2. Global Pharmacokinetics Services Market for Small Molecules, by Region, Forecast ($Mn, AGR%), 2020-2030
Table 4.3. Global Pharmacokinetics Services Market for Large Molecules, by Region, Forecast ($Mn, AGR%), 2020-2030
Table 6.1 North American Pharmacokinetics Services Market Forecast, by Country, 2020-2030 ($Mn, AGR%)
Table 6.2 North American Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 6.3 US Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 6.4 Canada Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 7.1 Europe Pharmacokinetics Services Market Forecast, by Country, 2020-2030 ($Mn, AGR%)
Table 7.2 Europe Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 7.3 Germany Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 7.4 France Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 7.5 UK Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 7.6 Spain Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 7.7 Italy Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 7.8 Rest of Europe Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 8.1 Asia-Pacific Pharmacokinetics Services Market Forecast, by Country, 2020-2030 ($Mn, AGR%)
Table 8.2 Asia-Pacific Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 8.3 China Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 8.4 Japan Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 8.5 India Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 8.6 Australia Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 8.7 Rest of Asia-Pacific Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 9.1 Latin America Pharmacokinetics Services Market Forecast, by Country, 2020-2030 ($Mn, AGR%)
Table 9.2 Latin America Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 9.3 Brazil Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 9.4 Mexico Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 9.5 Rest of Latin America Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 10.1 Middle East & Africa Pharmacokinetics Services Market Forecast, by Country, 2020-2030 ($Mn, AGR%)
Table 10.2 Middle East & Africa Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 10.3 GCC Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 10.4 South Africa Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 11.8 Rest of Middle East & Africa Pharmacokinetics Services Market Forecast, by Drug Type, 2020-2030 ($Mn, AGR%)
Table 11.1 Evotec AG Product Portfolio
Table 11.2 Certara, L.P. Product Portfolio
Table 11.3 Pacific BioLabs Product Portfolio
Table 11.4 GVK Biosciences Private Limited Product Portfolio
Table 11.5 Shanghai Medicilon Inc. Product Portfolio
Table 11.6 Pharmaceutical Product Development, LLC Product Portfolio
Table 11.7 Charles River Laboratories International, Inc. Product Portfolio
Table 11.8 PAREXEL International Corporation Product Portfolio
Table 11.9 Eurofins Scientific, Inc. Product Portfolio
Table 11.10 Frontage Labs Product Portfolio
List of Figures
Figure 4.1. Global Pharmacokinetics Services Market, by Drug Type, Forecast ($Mn) 2020-2030
Figure 5.1. Global Pharmacokinetics Services Market, by Region, Forecast ($Mn), 2020-2030
Figure 6.1 North American Pharmacokinetics Services Market Forecast, ($Mn), 2020-2030
Figure 7.1 Europe Pharmacokinetics Services Market Forecast, ($Mn), 2020-2030
Figure 8.1 Asia-Pacific Pharmacokinetics Services Market Forecast, ($Mn), 2020-2030
Figure 9.1 Latin America Pharmacokinetics Services Market Forecast, ($Mn), 2020-2030
Figure 10.1 Middle East & Africa Pharmacokinetics Services Market Forecast, ($Mn), 2020-2030
Figure 11.1 Evotec AG Sales Analysis ($Mn)
Figure 11.2 Certara, L.P. Sales Analysis ($Mn)
Figure 11.3 Pacific BioLabs Sales Analysis ($Mn)
Figure 11.4 GVK Biosciences Private Limited Sales Analysis ($Mn)
Figure 11.5 Shanghai Medicilon Inc. Sales Analysis ($Mn)
Figure 11.6 Pharmaceutical Product Development, LLC Sales Analysis ($Mn)
Figure 11.7 Charles River Laboratories International Sales Analysis ($Mn)
Figure 11.8 PAREXEL International Corporation Sales Analysis ($Mn)
Figure 11.9 Eurofins Scientific, Inc. Sales Analysis ($Mn)
Figure 11.10 Frontage Labs Sales Analysis ($Mn)
Absorption Systems
ADME Scope
Alta Sciences
Amri Global
Anthem Biosciences
Bio Tranex
Certara, L.P.
Charles River Laboratories International, Inc.
Creative Bioarray
Creative Biolabs
Criver
Cyprotex
DMPK
Eurofins Scientific, Inc.
Evotec AG
Frontage Labs
GVK Biosciences Private Limited
KCAS Bioanalytical Services
LGC Limited
LoveLace Biomedical
Medicilion
Micro Constants
Nexelis
Notrox Research
Nuventra
Octagon Services
Pacific BioLabs
PAREXEL International Corporation
Pfizer
Pharmaceutical Product Development, LLC
Pharmdev Group
Pharmidex
Q2 Lab Solutions
QPS
Quanticate
SGS SA
Shanghai Medicilon Inc.
Simcyp
Syngene
XYZAGEN